Pulmonary Cryptococcal Infection Complicating Gefitinib Therapy in a Patient With EGFR L858R‐Positive Lung Adenocarcinoma: A Case Report
Year: 2026
Type: article
Study design: Case Report
Abstract: In patients with EGFR-mutant lung adenocarcinoma receiving gefitinib or other EGFR-TKIs, the development of new pulmonary nodules should not be hastily attributed to disease progression; secondary pulmonary cryptococcosis should be considered in the differential diagnosis.
Source: Clinical Case Reports
DOI: 10.1002/ccr3.72684
Institution: Zunyi Medical University
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,820
OpenAlex ID: W7160862501